Intel Is Up 170% This Year. Should Investors Buy or Be Worried?

Intel’s comeback is being driven by a 9.9% U.S. government equity stake, a new CEO-led turnaround, and 22% year-over-year growth in Q1 2026 data center revenue. The company also expanded its partnership with Alphabet on AI infrastructure, but it remains unprofitable with a $4.28 billion quarterly net loss and a trailing P/E above 900. The article is cautiously positive on Intel’s execution progress, while warning that the stock’s 170% year-to-date surge may have outpaced fundamentals.

Analysis

The market is pricing Intel less like a cyclical turnaround and more like a national strategic asset, which matters because that valuation regime tends to persist until the narrative breaks. The government stake lowers perceived bankruptcy/financing risk and effectively turns the equity into a policy-backed call option on domestic foundry capacity; that can keep multiple expansion going even if operating results lag. The second-order winner is likely the domestic semiconductor supply chain—equipment, advanced packaging, and power/thermal vendors—because Intel’s capex intensity has to rise before revenue quality can improve.

The bigger near-term risk is that the stock has likely outrun the evidence base. A >900x trailing P/E implies the market is capitalizing future optionality, not current earnings power, so any miss on AI server share, foundry yield, or customer concentration will likely compress the multiple faster than fundamentals improve. The key timing issue is months, not days: the next 1-2 earnings cycles need to show sustained gross margin repair and credible external foundry traction, otherwise the move becomes a classic policy-driven squeeze rather than a durable rerating.

Alphabet partnership headlines matter less for immediate revenue than for validation; the signal is that Intel is being treated as a strategic alternative in AI infrastructure procurement. That said, if hyperscalers use Intel mainly as leverage against Nvidia/AMD pricing, the upside may accrue more to buyers than to Intel shareholders. The contrarian view is that the market is underestimating how much of Intel’s advance is driven by scarcity of domestic AI/CPU alternatives rather than improving economics, which makes the setup vulnerable once the ‘national champion’ trade gets crowded.

Key Decisions for Investors

• Fade the enthusiasm with a defined-risk short: buy INTC put spreads out 3-6 months; target a pullback on any earnings disappointment or guidance reset. Risk/reward is attractive because the stock is priced for near-perfect execution while fundamentals are still negative.
• Long GOOGL vs short INTC as a cleaner AI-infrastructure expression over the next 1-2 quarters. Alphabet gets optionality from diversified AI spend, while Intel carries turnaround and policy-exit risk; use a market-neutral pair to isolate execution.
• Overweight equipment and packaging beneficiaries versus INTC: look at ASML, AMAT, LRCX, and related advanced-packaging names on any weakness. If Intel’s capex is real, these names monetize the spend earlier than Intel monetizes the output.
• If forced to own INTC, size it as a momentum trade only and add on dips after confirmed order wins, not on headline-driven spikes. Take profits into strength above prior highs because valuation compression risk dominates once buying pressure fades.
• Avoid chasing NVDA as a direct hedge here; the article’s incremental signal is more about domestic supply-chain diversification than near-term GPU demand. NVDA remains structurally stronger, but the cleaner trade is to short over-owned Intel beta rather than fight the AI leader.